Lexagene Holdings Inc. Brief: Up 21% Early Friday As BioPharma Engages It in Second Feasibility Study; LXG Cancels Plans to Reprice Meridian's Warrants
Lexagene Holdings Inc. Brief: Up 21% Early Friday As BioPharma Engages It in Second Feasibility Study; LXG Cancels Plans to Reprice Meridian's Warrants
Lexagene Holdings Inc. 简介：由于BioPharma参与第二项可行性研究，周五早些时候上涨了21％；LXG取消了对Meridian认股权证进行重新定价的计划
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册